| Co-factors | Glucocorticoids | Treatment of AIDS risk groups | Treatment of AIDS |
| Prevalence and patterns of use of concomitant medications among participants in three multicenter human immunodeficiency virus type 1 clinical trials. |
| Fogelman I, Lim L, Bassett R, Volberding P, Fischl MA, Stanley K, Cotton DJ, for the AIDS Clinical Trials Group. |
| | Most, perhaps all American HIV-positives at risk for AIDS also take other "concomitant medications" that have known immunosuppressive and other detrimental effects, such as cortisones, dapsone, pentamidine and others. |
| | Journal of Acquired Immune Deficiency Syndromes 1994; 7: 1057-1063. | 1994 |